Adiponectin and development of type 2 diabetes in the Pima Indian population.
By R. Lindsay, T. Funahashi, R. Hanson, Yuji Matsuzawa, Sachiyo Tanaka, P. Tataranni, W. Knowler, J. Krakoff. The Lancet, 2002
1,162 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Endocrine and Autonomic Systems, Epidemiology
View Paper: https://www.semanticscholar.org/paper/29fd8b807e19e5112b2b65d5015e83dc9f3bc3f6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Endocrine and Autonomic Systems
- H. Fang
- R. L. Judd
- P. Havel
- Toshimasa Yamauchi
- F. B. Hu
- Takashi Kadowaki
- B. K. Pedersen
- A. M. Petersen
In Epidemiology
- H. Fang
- R. L. Judd
- B. K. Pedersen
- Takashi Kadowaki
- F. B. Hu
- Toshimasa Yamauchi
- G. Hotamisligil
- I. Shimomura
Citations in the corpus
- The anti-inflammatory effect of exercise. (2005, background): “Low-grade chronic inflammation is reflected by increased C-reactive protein (CRP) concentrations and increased systemic levels of some cytokines (118) and several reports investigating various markers of inflammation in different population groups have confirmed an association between low-grade syst”
- Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. (2003, background): “In a nested case-control study in Pima Indians, high plasma adiponectin concentrations strongly predicted a lower incidence rate of type 2 diabetes independent of obesity (6).”
- Adiponectin Regulation and Function (2018, positive): “In Pima Indians, low basal levels of adiponectin were found to predict decreased insulin sensitivity regardless of adiposity (171).”
- Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. (2013, background): “, 2011a), whereas serum adiponectin levels are decreased (Weyer et al., 2001; Lindsay et al., 2002).”
- Adiponectin: action, regulation and association to insulin sensitivity (2005, background): “obesity reviews 6 , 13–21 Adiponectin levels are reduced in patients with cardiovascular disease (26) and in diabetics (27) and from epidemiological studies low levels of adiponectin are found to be a predictor of the later development of type 2 diabetes (28,29) and myocardial infarction (30,31).”
- Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. (2004, background): “Lindsay et al. (120) reported that elevated serum total -globulin levels, a nonspecific measure of the adaptive immune system, predict the development of type 2 diabetes in Pima Indians.”
- Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. (2003, background): “In Pima Indians, hypoadiponectinemia is a strong predictor for the development of type 2 diabetes (16).”
- The role of the novel adipocyte-derived hormone adiponectin in human disease. (2003, background): “A case-control study in 140 Pima Indians has also shown that subjects with low concentrations of adiponectin are more likely to develop type 2 diabetes than those with high concentrations ( 44 ).”
- Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. (2003, background): “That the association remained large and statistically significant in white nonsmokers after full adjustment suggests that it does reflect direct causal links between inflammatory mediators generated by adipose tissue, such as tumor necrosis factor- , adiponectin (6) and angiotensin II, and diabetes.”